Andrew Davis

Andrew Davis

Corporate Officer/Principal presso DYNAVAX TECHNOLOGIES CORPORATION
40 anni
Health Technology
Consumer Services

Profilo

Andrew Davis is currently Director at UTILITY therapeutics Ltd. since 2019 and Chief Business Officer at Dynavax Technologies Corp.
starting in 2024.
Formerly, Mr. Davis was Chairman at VectivBio Holding AG; Director at BioMarck Pharmaceuticals Ltd. from 2020 to 2022; Senior Vice President-Business Development at Ironwood Pharmaceuticals, Inc. in 2021; Senior Vice President-Business Development at Bausch Health US LLC from 2014 to 2016; Vice President-Corporate Development at Bausch Health Cos., Inc.; Chief Business Development Officer at iNova Pharmaceuticals (Pty) Ltd. (South Africa) from 2017 to 2021; and Head-Oncology Business Development at Merck & Co., Inc. from 2016 to 2017.
Education includes undergraduate studies at Boston University.

Posizioni attive di Andrew Davis

SocietàPosizioneInizio
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01/11/2024
Direttore/Membro del Consiglio 01/08/2019

Precedenti posizioni note di Andrew Davis

SocietàPosizioneFine
IRONWOOD PHARMACEUTICALS, INC. Corporate Officer/Principal 22/11/2024
Direttore/Membro del Consiglio 01/10/2022
Corporate Officer/Principal 01/05/2021
MERCK & CO., INC. Corporate Officer/Principal 01/09/2017
Corporate Officer/Principal 01/01/2016
Vedi nel dettaglio l'esperienza di Andrew Davis

Formazione di Andrew Davis

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

15

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Andrew Davis